Average Co-Inventor Count = 6.54
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merrimack Pharmaceuticals, Inc. (6 from 52 patents)
6 patents:
1. 10072299 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
2. 9902999 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
3. 9885087 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
4. 9226964 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
5. 9044460 - Antibodies against epidermal growth factor receptor (EGFR) and uses thereof
6. 8691231 - Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies